PFM Health Sciences, LP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 15 filers reported holding ACORDA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,000,000
-16.7%
2,000,0000.0%0.04%
-36.4%
Q3 2020$1,200,000
-29.9%
2,000,0000.0%0.06%
-38.2%
Q2 2020$1,713,000
-0.5%
2,000,0000.0%0.09%
-36.9%
Q1 2020$1,721,000
-95.6%
2,000,000
-96.0%
0.14%
-87.9%
Q3 2019$39,319,000
+167.1%
49,764,825
+189.2%
1.16%
+314.6%
Q2 2019$14,723,000
-82.4%
17,207,017
-81.7%
0.28%
-84.8%
Q1 2019$83,582,000
+10.5%
94,177,000
+3.6%
1.85%
-8.1%
Q4 2018$75,652,000
-6.6%
90,886,000
-4.8%
2.01%
+69.3%
Q3 2018$81,023,000
+110.5%
95,433,000
+140.9%
1.19%
+96.8%
Q2 2018$38,486,000
+68.0%
39,619,000
+58.1%
0.60%
+29.7%
Q1 2018$22,907,000
+9.7%
25,065,000
+2.2%
0.46%
-6.1%
Q4 2017$20,885,000
+7.7%
24,516,000
+14.8%
0.50%
+29.9%
Q3 2017$19,386,000
+81.4%
21,362,000
+72.6%
0.38%
+32.3%
Q2 2017$10,685,000
-66.7%
12,380,000
-65.6%
0.29%
-70.9%
Q1 2016$32,115,00036,008,0000.99%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
LINDEN ADVISORS LP 15,510,000$16,119,0003.21%
GRACE BROTHERS MANAGEMENT LLC 2,500,000$2,592,0002.44%
Mohican Financial Management, LLC 3,000,000$3,113,0001.52%
Wellesley Asset Management 20,902$21,872,0001.36%
Fore Research & Management, LP 31,595,000$32,937,0000.97%
Man Investments (CH) AG 1,700,000$1,787,0000.93%
SYMPHONY ASSET MANAGEMENT LLC 7,834,000$8,128,0000.84%
BASSO CAPITAL MANAGEMENT, L.P. 5,000,000$5,150,0000.79%
Baker Brothers Advisors 60,000,000$62,050,0000.78%
CAMDEN ASSET MANAGEMENT L P /CA 10,225,000$10,608,0000.44%
View complete list of ACORDA THERAPEUTICS INC shareholders